Page last updated: 2024-08-23

pinaverium and mebeverine

pinaverium has been researched along with mebeverine in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, FY; Chang, SS; Chen, CY; Kang, LJ; Lee, SD; Lu, CL; Lu, RH	1
Mearin, F	1
Annaházi, A; Róka, R; Rosztóczy, A; Wittmann, T	1
Afifi, AF; Chen, S; El-Khayat, HR; Elsawah, H; Fatah, AA; Hartleb, M; Hassan, MF; Hou, X; Janssen-van Solingen, G; Jurkowska, G; Linke, K; Malecka-Panas, E; Nouh, A; Osthoff Rueda, R; Rucker Joerg, I; Sánchez Núñez, JM; Sha, W; Walczak, M; Yu, X; Zhang, Y	1

Reviews

2 review(s) available for pinaverium and mebeverine

Article	Year
[Drug treatment of irritable bowel syndrome: an unmet need]. Gastroenterologia y hepatologia, 2007, Volume: 30, Issue:3 Topics: Abdominal Pain; Analgesics; Antidepressive Agents, Tricyclic; Antidiarrheals; Carbolines; Controlled Clinical Trials as Topic; Diarrhea; Dicyclomine; Gastrointestinal Agents; Humans; Irritable Bowel Syndrome; Life Style; Loperamide; Meta-Analysis as Topic; Morpholines; Muscarinic Antagonists; Odds Ratio; Parasympatholytics; Phenethylamines; Quality of Life; Risk; Scopolamine; Scopolamine Derivatives; Serotonin Antagonists; Serotonin Receptor Agonists; Surveys and Questionnaires; Time Factors; Treatment Outcome; Trimebutine	2007
Role of antispasmodics in the treatment of irritable bowel syndrome. World journal of gastroenterology, 2014, May-28, Volume: 20, Issue:20 Topics: Abdominal Pain; Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Disease Models, Animal; Humans; Irritable Bowel Syndrome; Morpholines; Parasympatholytics; Phenethylamines; Quaternary Ammonium Compounds; Randomized Controlled Trials as Topic; Treatment Outcome	2014

Article

Year

[Drug treatment of irritable bowel syndrome: an unmet need].

Gastroenterologia y hepatologia, 2007, Volume: 30, Issue:3

Topics: Abdominal Pain; Analgesics; Antidepressive Agents, Tricyclic; Antidiarrheals; Carbolines; Controlled Clinical Trials as Topic; Diarrhea; Dicyclomine; Gastrointestinal Agents; Humans; Irritable Bowel Syndrome; Life Style; Loperamide; Meta-Analysis as Topic; Morpholines; Muscarinic Antagonists; Odds Ratio; Parasympatholytics; Phenethylamines; Quality of Life; Risk; Scopolamine; Scopolamine Derivatives; Serotonin Antagonists; Serotonin Receptor Agonists; Surveys and Questionnaires; Time Factors; Treatment Outcome; Trimebutine

2007

Role of antispasmodics in the treatment of irritable bowel syndrome.

World journal of gastroenterology, 2014, May-28, Volume: 20, Issue:20

Topics: Abdominal Pain; Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Disease Models, Animal; Humans; Irritable Bowel Syndrome; Morpholines; Parasympatholytics; Phenethylamines; Quaternary Ammonium Compounds; Randomized Controlled Trials as Topic; Treatment Outcome

2014

Trials

1 trial(s) available for pinaverium and mebeverine

Article	Year
Effect of a calcium channel blocker and antispasmodic in diarrhoea-predominant irritable bowel syndrome. Journal of gastroenterology and hepatology, 2000, Volume: 15, Issue:8 Topics: Calcium Channel Blockers; Colonic Diseases, Functional; Diarrhea; Female; Gastrointestinal Motility; Humans; Immunoenzyme Techniques; Male; Middle Aged; Morpholines; Neuropeptide Y; Parasympatholytics; Phenethylamines; Statistics, Nonparametric; Substance P; Surveys and Questionnaires; Treatment Outcome	2000

Article

Year

Effect of a calcium channel blocker and antispasmodic in diarrhoea-predominant irritable bowel syndrome.

Journal of gastroenterology and hepatology, 2000, Volume: 15, Issue:8

Topics: Calcium Channel Blockers; Colonic Diseases, Functional; Diarrhea; Female; Gastrointestinal Motility; Humans; Immunoenzyme Techniques; Male; Middle Aged; Morpholines; Neuropeptide Y; Parasympatholytics; Phenethylamines; Statistics, Nonparametric; Substance P; Surveys and Questionnaires; Treatment Outcome

2000

Other Studies

1 other study(ies) available for pinaverium and mebeverine

Article	Year
Quality of life in patients with Irritable Bowel Syndrome (IBS), assessed using the IBS-Quality of Life (IBS-QOL) measure after 4 and 8 weeks of treatment with mebeverine hydrochloride or pinaverium bromide: results of an international prospective observa Clinical drug investigation, 2014, Volume: 34, Issue:11 Topics: Adult; Aged; Aged, 80 and over; China; Cohort Studies; Drug Administration Schedule; Egypt; Humans; Irritable Bowel Syndrome; Male; Mexico; Middle Aged; Morpholines; Phenethylamines; Poland; Prospective Studies; Quality of Life; Young Adult	2014

Article

Year

Quality of life in patients with Irritable Bowel Syndrome (IBS), assessed using the IBS-Quality of Life (IBS-QOL) measure after 4 and 8 weeks of treatment with mebeverine hydrochloride or pinaverium bromide: results of an international prospective observa

Clinical drug investigation, 2014, Volume: 34, Issue:11

Topics: Adult; Aged; Aged, 80 and over; China; Cohort Studies; Drug Administration Schedule; Egypt; Humans; Irritable Bowel Syndrome; Male; Mexico; Middle Aged; Morpholines; Phenethylamines; Poland; Prospective Studies; Quality of Life; Young Adult

2014